JSE faces pressure on Friday as economic toll of Covid-19 becomes clearer
Dismal economic data out of the eurozone and the failure of the drug remdesivir is sapping risk appetite on Friday morning
24 April 2020 - 07:07
The JSE could be under pressure on Friday morning, as investors digest dire economic data out of the eurozone, and the failure of the drug remdesivir in a clinical trial.
Markets had been boosted by reports that remdesivir had helped Covid-19 patients with severe symptoms recently, however, the Financial Times has reported (https://www.ft.com/content/0a4872d1-4cac-4040-846f-ce32daa09d99) that the drug “flopped” in its first clinical trial...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.